All lobbying filings

DH DIAGNOSTICS LLC

Lobbying for DH DIAGNOSTICS, LLC · Diagnostics manufacturers

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $220,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 9

S 2761
RESULTS Act
HR 5269
RESULTS Act
S 1399
Health Tech Investment Act
HR 6197
Health Tech Investment Act
S 3287
Supportive Services for National Guard and Reserve Veterans and Families Act
HR 6130
ASAP Act
HR 7352
PASTEUR Act of 2026
S 4875
PASTEUR Act of 2026
S 1941
Cure Hepatitis C Act of 2025

Lobbying activity 4

Medicare/Medicaid

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Budget/Appropriations

Funding for diagnostics

Trade (domestic/foreign)

Medical device supply-chain resilience, including semiconductor and memory-chip availability.

Health Issues

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.